Client Success: Commercial Assessment for Crossover Investor-Funded Private Biotech
![](https://rnaadvisors.com/wp-content/uploads/2016/10/iStock-617382644.jpg)
THE PROBLEM: Novel technology platform could be used across a wide range of rare diseases, so executive team and board want an independent, evidence-based view of commercial opportunity to complement the scientific analysis. THE SOLUTION: Interviews with KOL physician-scientists to understand unmet need and applicability of technology to targets, detailed pipeline analysis, market modeling and […]